-
Mashup Score: 190
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40% – Full Text View.
Source: classic.clinicaltrials.govCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307 - Full Text View - ClinicalTrials.gov - 5 month(s) ago
To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307 – Full Text View.
Source: classic.clinicaltrials.govCategories: General Medicine News, Hem/OncsTweet-
RT @onco_park: #HCC #GPC3 #IL18 https://t.co/icPWUhV3yQ https://t.co/xkhFeBLuOe
-
-
Mashup Score: 0LVEF Prediction During ACS Using AI Algorithm Applied on Coronary Angiogram Videos - Full Text View - ClinicalTrials.gov - 6 month(s) ago
LVEF Prediction During ACS Using AI Algorithm Applied on Coronary Angiogram Videos – Full Text View.
Source: classic.clinicaltrials.govCategories: General Medicine News, CardiologistsTweet-
🥸 28. In the cath lab - there are a lot of applications (small section in the manuscript) 😱@adnanalkhouli presented in @SCAI on some of these applications. 👇👇👇 https://t.co/ZaHyVdUbnj https://t.co/kgEI85x7Ej
-
-
Mashup Score: 14Cluster Randomized Trial of a Digital Quality Improvement Intervention on LDLCholesterol Control - Full Text View - ClinicalTrials.gov - 6 month(s) ago
Cluster Randomized Trial of a Digital Quality Improvement Intervention on LDLCholesterol Control – Full Text View.
Source: classic.clinicaltrials.govCategories: General Medicine News, CardiologistsTweet-
Can digital technology help control LDL-C? This is what we're trying to prove in SAPPHIRE-LDL-C https://t.co/1WpbJWVrwn @JuliaMachline @OtavioBerwanger @RauppMd @ProfKausikRay @cpcannon #cholesterol #cardiovascular https://t.co/2Yvfvi5ALo
-
-
Mashup Score: 3Induction FLOT With CROSS CRT for Esophageal Cancer - Full Text View - ClinicalTrials.gov - 6 month(s) ago
Induction FLOT With CROSS CRT for Esophageal Cancer – Full Text View.
Source: classic.clinicaltrials.govCategories: General Medicine News, Oncologists2Tweet-
Agree 💯! Plug for our trial at @CUCancerCenter evaluating neoadjuvant FLOT—>CROSS—>surgery +/- nivolumab for localized GEJ/esophageal cancer. https://t.co/yq7D0EWqW6 https://t.co/3bItVHEZeF
-
-
Mashup Score: 1Clinical Study of Ivonescimab for First-line Treatment of Metastatic Squamous NSCLC Patients - Full Text View - ClinicalTrials.gov - 6 month(s) ago
Clinical Study of Ivonescimab for First-line Treatment of Metastatic Squamous NSCLC Patients – Full Text View.
Source: classic.clinicaltrials.govCategories: General Medicine News, General HCPsTweet-
RT @spontonic: @jordixiol Launched on Halloween... https://t.co/MfPabphoMe
-
-
Mashup Score: 8
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors – Full Text View.
Source: classic.clinicaltrials.govCategories: General Medicine News, Hem/OncsTweet-
For my colleagues in the U.S., before you start a patient on RLT for lung NET, please consider the Alliance A021901 trial of Lu-177 DOTATATE vs. everolimus but - a well designed trial of great importance. @thomashopemd - do we have a catchy name for it? https://t.co/IsfP39ckhI
-
-
Mashup Score: 20
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes – Full Text View.
Source: classic.clinicaltrials.govCategories: General Medicine News, CardiologistsTweet-
#FLOW Diabetic Retinopathy Reassuring that diabetic retinopathy AEs were similar btw arms in this high risk cohort Ongoing dedicated longterm (5y) P3 #FOCUS RCT will clear the air, evaluating sema in 1500 pts w T2D on progression of diabetic eye disease https://t.co/l0zdXAhtZO https://t.co/6RGr6EcE9R https://t.co/WuqsMpRVet
-
-
Mashup Score: 12
A Randomised, Phase 3 Non-inferiority Study of DOR/3TC/TDF Compared to DTG/TAF/FTC in Participants Infected With HIV-1 Starting First-line Antiretroviral Therapy – Full Text View.
Source: classic.clinicaltrials.govCategories: General Medicine News, Infectious DiseaseTweet-
Doravirine studies with a metabolic focus to watch out for: 1. OPTI-DOR: 1st line DOR/3TC/TDF vs TDF/FTC/DTG in South Africa https://t.co/zNo1dM5c0w 2. ELDORADO: 1st line DOR/3TC/TDF vs TDF/XTC/DTG in S America, Africa & France https://t.co/Qx703kABNN #euhivhep @FrancoisVenter3 https://t.co/iUbQKMwyw8
-
-
Mashup Score: 19
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) – Full Text View.
Source: classic.clinicaltrials.govCategories: General Medicine News, CardiologistsTweet-
More trials in #ATTR cardiomyopathy MAGNITUDE is a 765 patient trial randomizing patients with ATTR CM to NTLA-2001 vs placebo https://t.co/UtFlaymGj3 #CardioTwitter https://t.co/CthPYiklqd
-
🔥🔥 #FINEARTSHF has officially completed enrollment & event-driven follow-up! #FINEARTSHF (n=6001) is the largest RCT of an MRA in patients with HF—primary results to be presented at an upcoming meeting Check out initial publications to set the stage🧵 https://t.co/KcWYMvnw9K https://t.co/MrUeid84Ho